DK1140068T3 - Doramectin formulations - Google Patents

Doramectin formulations

Info

Publication number
DK1140068T3
DK1140068T3 DK99954291T DK99954291T DK1140068T3 DK 1140068 T3 DK1140068 T3 DK 1140068T3 DK 99954291 T DK99954291 T DK 99954291T DK 99954291 T DK99954291 T DK 99954291T DK 1140068 T3 DK1140068 T3 DK 1140068T3
Authority
DK
Denmark
Prior art keywords
doramectin
formulations
doramectin formulations
Prior art date
Application number
DK99954291T
Other languages
Danish (da)
English (en)
Inventor
Valerie Denise Pfizer Harding
Stephen Richard Pfizer C Wicks
Timothy Michael Pfizer C Lukas
Snezana Pfizer Centr Milojevic
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1140068T3 publication Critical patent/DK1140068T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99954291T 1998-12-16 1999-11-22 Doramectin formulations DK1140068T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
DK1140068T3 true DK1140068T3 (da) 2004-07-12

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99954291T DK1140068T3 (da) 1998-12-16 1999-11-22 Doramectin formulations

Country Status (21)

Country Link
US (1) US6699847B2 (zh)
EP (1) EP1140068B1 (zh)
JP (1) JP3848537B2 (zh)
AP (1) AP9901699A0 (zh)
AR (1) AR019499A1 (zh)
AT (1) ATE269074T1 (zh)
AU (1) AU762892B2 (zh)
BR (1) BR9916265A (zh)
CA (1) CA2355102C (zh)
DE (1) DE69918165T2 (zh)
DK (1) DK1140068T3 (zh)
ES (1) ES2221455T3 (zh)
GB (1) GB9827727D0 (zh)
GT (1) GT199900213A (zh)
MA (1) MA26710A1 (zh)
PA (1) PA8486601A1 (zh)
PE (1) PE20001244A1 (zh)
PT (1) PT1140068E (zh)
TN (1) TNSN99225A1 (zh)
TW (1) TW524691B (zh)
WO (1) WO2000035445A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413866C (zh) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 核黄素衍生物及其制备方法与应用
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
AU2009271299B2 (en) * 2008-06-24 2014-09-11 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
JP2012517994A (ja) 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
EP2916702B1 (en) 2012-11-09 2019-09-18 Aktiebolaget Electrolux Blender
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
EP0115001B1 (de) 1982-12-28 1988-06-15 Bayer Ag Stabile Aminoglykosid-Penicillin-Injektionsformulierungen
EP0140255B1 (en) 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
IL79765A (en) 1985-08-23 1992-02-16 Lilly Co Eli Injectable sustained release formulations of bovine somatotropin
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ATE180671T1 (de) 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Also Published As

Publication number Publication date
CA2355102C (en) 2006-07-11
PE20001244A1 (es) 2000-11-07
GB9827727D0 (en) 1999-02-10
US6699847B2 (en) 2004-03-02
AR019499A1 (es) 2002-02-20
TNSN99225A1 (fr) 2005-11-10
PT1140068E (pt) 2004-09-30
PA8486601A1 (es) 2000-09-29
AU762892B2 (en) 2003-07-10
DE69918165T2 (de) 2004-10-14
JP2002532422A (ja) 2002-10-02
EP1140068A1 (en) 2001-10-10
DE69918165D1 (de) 2004-07-22
EP1140068B1 (en) 2004-06-16
TW524691B (en) 2003-03-21
US20020142972A1 (en) 2002-10-03
BR9916265A (pt) 2001-11-20
CA2355102A1 (en) 2000-06-22
AU1069900A (en) 2000-07-03
JP3848537B2 (ja) 2006-11-22
ATE269074T1 (de) 2004-07-15
GT199900213A (es) 2001-06-07
AP9901699A0 (en) 2001-05-22
MA26710A1 (fr) 2004-12-20
WO2000035445A1 (en) 2000-06-22
ES2221455T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
PT1130966E (pt) Formulacoes antiparasitarias
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
ATE341990T1 (de) Sigmidoskop
ID26162A (id) Turunan-turunan benzilbifenil biosida
ID29635A (id) Formulasi mikrokapsul
DE69927758D1 (de) Imidosilan-Zusammensetzungen
IS6398A (is) Lyfjablöndur
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
ID27655A (id) Formulasi mikrokapsul
ATE262513T1 (de) Benzoylpyridazine
DK0969233T3 (da) Strömningsbegrænser
ATE269074T1 (de) Doramectinformulierungen
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE59808995D1 (de) Endomikroskopsystem
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
PT1076660E (pt) (4-bromopirazol-3-il)-benzazolos substituidos
ATA126298A (de) Verpuffungsklappe
SE9800170D0 (sv) Formulation